Viewing Study NCT01624766


Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2025-12-28 @ 5:43 AM
Study NCT ID: NCT01624766
Status: COMPLETED
Last Update Posted: 2021-02-25
First Post: 2012-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module